Ann Liver Transplant.  2023 Nov;3(2):73-79. 10.52604/alt.23.0020.

Living donor liver transplantation for Wilson disease: A collective review

• Park JI
• Chung YK

• KMID: 2560926
• DOI: http://doi.org/10.52604/alt.23.0020

Abstract

Wilson disease (WD) is a recognized metabolic disorder characterized by abnormal copper accumulation and excretion in the human body. The liver-related symptoms may range from acute liver failure to chronic liver disease. Liver transplantation (LT) is primarily indicated for two conditions of WD as acute liver failure and chronic liver disease. LT offers a crucial lifeline for those with WD, with high success rates for graft and patient survival. Living donor liver transplantation (LDLT) recipients for WD generally exhibit superior survival rates, including graft survival, compared to those undergoing LT for other conditions. However, they are still susceptible to the usual risks associated with LDLT. This study intended to review the LDLT cases for WD with acute liver failure and chronic liver disease in the literature. This review included 12 LDLT studies and case reports from Japan (n=3), Turkey (n=2), India (n=2), China (n=2), Saudi Arabia (n=1), Korea (n=1), and United Arab Emirates (n=1). The findings of this review reinforce the efficacy of LDLT in WD, particularly in instances of acute liver failure, while also acknowledging its effectiveness in chronic liver disease.

Keyword

Wilson disease; Acute liver failure; Copper metabolism; Living donors; Liver transplantation

Reference

1. Catana AM, Medici V. 2012; Liver transplantation for Wilson disease. World J Hepatol. 4:5–10. DOI: 10.4254/wjh.v4.i1.5. PMID: 22312450. PMCID: PMC3272077.

2. Choudhary NS, Saigal S, Saraf N, Rastogi A, Goja S, Bhangui P, et al. 2018; Outcome of living donor liver transplantation for Wilson's disease in adults: a single center experience. J Clin Exp Hepatol. 8:132–135. DOI: 10.1016/j.jceh.2017.11.003. PMID: 29892175. PMCID: PMC5992308.

3. Wilson GC, Quillin RC 3rd, Wima K, Sutton JM, Hoehn RS, Hanseman DJ, et al. 2014; Is liver transplantation safe and effective in elderly (≥70 years) recipients? A case-controlled analysis. HPB (Oxford). 16:1088–1094. DOI: 10.1111/hpb.12312. PMID: 25099347. PMCID: PMC4253332.

4. European Association for Study of Liver. 2012; EASL clinical practice guidelines: Wilson's disease. J Hepatol. 56:671–685. DOI: 10.1016/j.jhep.2011.11.007. PMID: 22340672.

5. Schilsky ML. 2014; Liver transplantation for Wilson's disease. Ann N Y Acad Sci. 1315:45–49. DOI: 10.1111/nyas.12454. PMID: 24820352.

6. Kamei H, Imai H, Onishi Y, Sugimoto H, Suzuki K, Ogura Y. 2015; Living donor liver transplantation using a liver graft with congenital intrahepatic portosystemic shunt. Transplant Direct. 2:e46. DOI: 10.1097/TXD.0000000000000562. PMID: 27500240. PMCID: PMC4946503.

7. Wilson RE. 1976; Transplantation. Surg Gynecol Obstet. 142:219–224.

8. Crossin JD, Muradali D, Wilson SR. 2003; US of liver transplants: normal and abnormal. Radiographics. 23:1093–1114. DOI: 10.1148/rg.235035031. PMID: 12975502.

9. Morioka D, Kasahara M, Takada Y, Corrales JP, Yoshizawa A, Sakamoto S, et al. 2005; Living donor liver transplantation for pediatric patients with inheritable metabolic disorders. Am J Transplant. 5:2754–2763. DOI: 10.1111/j.1600-6143.2005.01084.x. PMID: 16212637.

10. Ionescu MI, Edwin ID, Wilson CH, Saikia SE, Talbot D. 2018; Orthotopic liver transplantation for hereditary hemorrhagic telangiectasia and MEN type I syndrome - case report and review of literature. Chirurgia (Bucur). 113:837–848. DOI: 10.21614/chirurgia.113.6.837. PMID: 30596371.

11. Bahador A, Salahi H, Nikeghbalian S, Dehghani SM, Kakaei F, Sabet B, et al. 2009; Split liver transplantation in Shiraz Transplant Center. Transplant Proc. 41:2872–2874. DOI: 10.1016/j.transproceed.2009.07.052. PMID: 19765460.

12. Parikh A, Washburn KW, Matsuoka L, Pandit U, Kim JE, Almeda J, et al. 2015; A multicenter study of 30 days complications after deceased donor liver transplantation in the model for end-stage liver disease score era. Liver Transpl. 21:1160–1168. DOI: 10.1002/lt.24181. PMID: 25991395.

13. Acarlı K. 2017; Liver transplantation for hepatocellular carcinoma: "experience of memorial Sisli Hospital". J Gastrointest Cancer. 48:272–273. DOI: 10.1007/s12029-017-9966-1. PMID: 28647820.

14. Yankol Y, Fernandez LA, Kanmaz T, Leverson GE, Mezrich JD, Foley D, et al. 2016; Results of pediatric living donor compared to deceased donor liver transplantation in the PELD/MELD era: experience from two centers on two different continents. Pediatr Transplant. 20:72–82. DOI: 10.1111/petr.12641. PMID: 26861217.

15. Okur MH, Yankol Y, Cimşit B, Mecit N, Ertuğrul G, Kanmaz T, et al. 2019; Liver transplant in children with hepatoblastoma. Exp Clin Transplant. 17:644–647.

16. Kanmaz T, Yankol Y, Mecit N, Durmaz O, Acarli K, Kalayoğlu M. 2014; Pediatric liver transplant: a single-center study of 100 consecutive patients. Exp Clin Transplant. 12:41–45. DOI: 10.6002/ect.2013.0016. PMID: 24471723.

17. Dal MB, Alim A, Acarli K. 2021; The advantage of early liver transplantation for Wilson's disease using living donors. Prz Gastroenterol. 16:213–218. DOI: 10.5114/pg.2021.108990. PMID: 34584582. PMCID: PMC8456762.

18. Kumar S. 2021; Emergent living donor liver transplantation for fulminant hepatic failure secondary to Wilson's disease. Cureus. 13:e20653. DOI: 10.7759/cureus.20653.

19. Valamparampil JJ, Sachan D, Shanmugam N, Reddy SM, Rela M. 2023; Emergency ABO-incompatible living donor liver transplantation in Wilson disease-induced acute liver failure. Asian J Transfus Sci. 17:128–130.

20. Huang Y, Takatsuki M, Soyama A, Hidaka M, Ono S, Adachi T, et al. 2018; Living donor liver transplantation for Wilson's disease associated with fulminant hepatic failure: a case report. Am J Case Rep. 19:304–308. DOI: 10.12659/AJCR.907494. PMID: 29549236. PMCID: PMC5870679.

21. Tamura S, Sugawara Y, Kishi Y, Akamatsu N, Kaneko J, Makuuchi M. 2005; Living-related liver transplantation for Wilson's disease. Clin Transplant. 19:483–486. DOI: 10.1111/j.1399-0012.2005.00371.x. PMID: 16008592.

22. Wang XH, Cheng F, Zhang F, Li XC, Kong LB, Li GQ, et al. 2005; Living-related liver transplantation for Wilson's disease. Transpl Int. 18:651–656. DOI: 10.1111/j.1432-2277.2004.00074.x. PMID: 15910288.

23. Hosaagrahara Ramakrishna S, Kasala MB, Perumal K, Malleeswaran S, Patcha RV, Varghese J, et al. 2022; When push comes to shove! Emergency ABO-incompatible pediatric living donor liver transplant for acute Wilson's disease. J Clin Exp Hepatol. 12:658–663. DOI: 10.1016/j.jceh.2021.08.008. PMID: 35535085. PMCID: PMC9077158.

24. Cheng F, Li GQ, Zhang F, Li XC, Sun BC, Kong LB, et al. 2009; Outcomes of living-related liver transplantation for Wilson's disease: a single-center experience in China. Transplantation. 87:751–757. DOI: 10.1097/TP.0b013e318198a46e. PMID: 19295322.

25. Peedikayil MC, Al Ashgar HI, Al Mousa A, Al Sebayel M, Al Kahtani K, Alkhail FA. 2013; Liver transplantation in Wilson's disease: single center experience from Saudi Arabia. World J Hepatol. 5:127–132. DOI: 10.4254/wjh.v5.i3.127. PMID: 23556045. PMCID: PMC3612571.

26. Narumi S, Umehara M, Toyoki Y, Ishido K, Kudo D, Kimura N, et al. 2012; Liver transplantation for Wilson's disease in pediatric patients: decision making and timing. Transplant Proc. 44:478–480. DOI: 10.1016/j.transproceed.2012.01.024. PMID: 22410050.

27. Park YK, Kim BW, Wang HJ, Kim MW. 2008; Auxiliary partial orthotopic living donor liver transplantation in a patient with Wilson's disease: a case report. Transplant Proc. 40:3808–3809. DOI: 10.1016/j.transproceed.2008.07.128. PMID: 19100498.

28. Bariş Z, Saltik Temızel IN, Uslu N, Usta Y, Demır H, Gürakan F, et al. 2012; Acute liver failure in children: 20-year experience. Turk J Gastroenterol. 23:127–134. DOI: 10.4318/tjg.2012.0319. PMID: 22706740.

29. Guillaud O, Dumortier J, Sobesky R, Debray D, Wolf P, Vanlemmens C, et al. 2014; Long term results of liver transplantation for Wilson's disease: experience in France. J Hepatol. 60:579–589. DOI: 10.1016/j.jhep.2013.10.025. PMID: 24211743.

30. Russo MW, LaPointe-Rudow D, Kinkhabwala M, Emond J, Brown RS Jr. 2004; Impact of adult living donor liver transplantation on waiting time survival in candidates listed for liver transplantation. Am J Transplant. 4:427–431. DOI: 10.1111/j.1600-6143.2004.00336.x. PMID: 14961997.

31. Yuan D, Liu F, Wei YG, Li B, Yan LN, Wen TF, et al. 2012; Adult-to-adult living donor liver transplantation for acute liver failure in China. World J Gastroenterol. 18:7234–7241. DOI: 10.3748/wjg.v18.i48.7234. PMID: 23326128. PMCID: PMC3544025.

32. Yamashiki N, Sugawara Y, Tamura S, Nakayama N, Oketani M, Umeshita K, et al. 2012; Outcomes after living donor liver transplantation for acute liver failure in Japan: results of a nationwide survey. Liver Transpl. 18:1069–1077. DOI: 10.1002/lt.23469. PMID: 22577093.

33. Urrunaga NH, Rachakonda VP, Magder LS, Mindikoglu AL. 2014; Outcomes of living versus deceased donor liver transplantation for acute liver failure in the United States. Transplant Proc. 46:219–224. DOI: 10.1016/j.transproceed.2013.08.111. PMID: 24507055. PMCID: PMC3991302.

34. Mack CL, Ferrario M, Abecassis M, Whitington PF, Superina RA, Alonso EM. 2001; Living donor liver transplantation for children with liver failure and concurrent multiple organ system failure. Liver Transpl. 7:890–895. DOI: 10.1053/jlts.2001.27963. PMID: 11679988.

35. Mehrotra S, Mehta N, Rao PS, Lalwani S, Mangla V, Nundy S. 2018; Live donor liver transplantation for acute liver failure: a single center experience. Indian J Gastroenterol. 37:25–30. DOI: 10.1007/s12664-017-0812-y. PMID: 29455437.

36. Lee CF, Cheng CH, Wang YC, Soong RS, Wu TH, Chou HS, et al. 2015; Adult living donor liver transplantation across ABO-incompatibility. Medicine (Baltimore). 94:e1796. DOI: 10.1097/MD.0000000000001796. PMID: 26496313. PMCID: PMC4620780.

37. Kim JM, Kwon CH, Joh JW, Kang ES, Park JB, Lee JH, et al. 2013; ABO-incompatible living donor liver transplantation is suitable in patients without ABO-matched donor. J Hepatol. 59:1215–1222. DOI: 10.1016/j.jhep.2013.07.035. PMID: 23928408.

38. Yamamoto H, Uchida K, Kawabata S, Isono K, Miura K, Hayashida S, et al. 2018; Feasibility of monotherapy by rituximab without additional desensitization in ABO-incompatible living-donor liver transplantation. Transplantation. 102:97–104. DOI: 10.1097/TP.0000000000001956. PMID: 28938311.

39. Lee WC, Cheng CH, Lee CF, Hung HC, Lee JC, Wu TH, et al. 2022; Quick preparation of ABO-incompatible living donor liver transplantation for acute liver failure. Clin Transplant. 36:e14555. DOI: 10.1111/ctr.14555. PMID: 34874071.

40. Perry DK, Burns JM, Pollinger HS, Amiot BP, Gloor JM, Gores GJ, et al. 2009; Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production. Am J Transplant. 9:201–209. DOI: 10.1111/j.1600-6143.2008.02461.x. PMID: 18976291.

41. Neubert K, Meister S, Moser K, Weisel F, Maseda D, Amann K, et al. 2008; The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis. Nat Med. 14:748–755. DOI: 10.1038/nm1763. PMID: 18542049.

42. McDonald V, Leandro M. 2009; Rituximab in non-haematological disorders of adults and its mode of action. Br J Haematol. 146:233–246. DOI: 10.1111/j.1365-2141.2009.07718.x. PMID: 19466979.